Clearstead Advisors’s NanoViricides NNVC Stock Holding History

Clearstead Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$405	Hold	293	–	–	﹤0.01%	2988
2026 Q1	$268	Hold	293	–	–	﹤0.01%	2154
2025 Q4	$332	Hold	293	–	–	﹤0.01%	2360
2025 Q3	$419	Hold	293	–	–	﹤0.01%	2761
2025 Q2	$411	Hold	293	–	–	﹤0.01%	2509
2025 Q1	$343	Hold	293	–	–	﹤0.01%	2101
2024 Q4	$419	Hold	293	–	–	﹤0.01%	1993
2024 Q3	$440	Hold	293	–	–	﹤0.01%	1964
2024 Q2	$504	Hold	293	–	–	﹤0.01%	1934
2024 Q1	$534	Hold	293	–	–	﹤0.01%	1454
2023 Q4	$299	Hold	293	–	–	﹤0.01%	1478
2023 Q3	$393	Hold	293	–	–	﹤0.01%	1426
2023 Q2	$337	Hold	293	–	–	﹤0.01%	1327
2023 Q1	$344	Hold	293	–	–	﹤0.01%	1326
2022 Q4	$325	Hold	293	–	–	﹤0.01%	1258
2022 Q3	$1K	Hold	293	–	–	﹤0.01%	1174
2022 Q2	$1K	Buy	+293	New	+$539	﹤0.01%	1203
2021 Q2	–	Sell	-293	Closed	-$1K	–	1291
2021 Q1	$1K	Hold	293	–	–	﹤0.01%	1046
2020 Q4	$1K	Hold	293	–	–	﹤0.01%	939
2020 Q3	$1K	Hold	293	–	–	﹤0.01%	848
2020 Q2	$2K	Hold	293	–	–	﹤0.01%	746
2020 Q1	$2K	Buy	+293	New	+$2.07K	﹤0.01%	731

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Clearstead Advisors's NNVC Position: Q2 2026 in Review

Clearstead Advisors held its NanoViricides (NNVC) position steady in Q2 2026 at 293 shares worth $405. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

Clearstead Advisors first reported a position in NNVC in Q1 2020 and has held it in 22 quarters since. The position peaked at $2K in Q2 2020. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Clearstead Advisors held 293 shares of NanoViricides worth $405 as of Q2 2026.
Clearstead Advisors left its NanoViricides share count unchanged in Q2 2026.
NanoViricides made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2988 holding.
Clearstead Advisors first reported a position in NanoViricides in Q1 2020 and has held it in 22 quarters since.
Clearstead Advisors's NanoViricides position peaked at $2K in Q2 2020.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.